Amlodipine Besylate; Benazepril Hydrochloride Patent Expiration
Amlodipine Besylate; Benazepril Hydrochloride is Used for managing high blood pressure and cardiovascular conditions. It was first introduced by Sandoz Inc
Amlodipine Besylate; Benazepril Hydrochloride Patents
Given below is the list of patents protecting Amlodipine Besylate; Benazepril Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lotrel | US6162802 | Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor |
Dec 19, 2017
(Expired) | Sandoz |
Amlodipine Besylate; Benazepril Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List